Christian Schafmeister, Founder and President of Thirdlaw Molecular, explores the promise of Goldilocks-sized molecules, the chemistry and design principles behind them and the technologies enabling rapid development of high-affinity binders against previously undruggable targets. For decades, the pharmaceutical industry has thrived on a foundational paradigm: small molecules for intracellular targets… Read More
Cancer Research Horizons has signed a collaboration agreement to license the entire Twist Biopharma Solutions Library of Libraries. Under the terms of the agreement, Cancer Research Horizons will license Twist’s ‘Library of Libraries’, a collection of synthesised antibody libraries designed based on naturally occurring sequences that… Read More
Anita Ramanathan outlines four synthetic biology approaches that are improving and accelerating drug discovery. The brainchild of multidisciplinary experts in computer science, physics, engineering, and biology, the field of synthetic biology has not only rapidly progressed in the last few decades but it’s also becoming more accessible and cost-effective. Read More
